Dr. Charles Huang

Charles Huang is a global visionary and entrepreneur. He was born and grew up in Wuhan, China. After completing his bachelor’s degree in economics from Wuhan University in 1986 he obtained a British Council scholarship to study his MBA and PhD in Marketing at the University of Strathclyde in Glasgow, Scotland. Following his studies in the U.K, Dr. Huang went to Hong Kong and pioneered China equity research in investment banking there with unrivaled stock picking skills and impeccable stock market calls. In Hong Kong, Dr. Huang successfully led and participated in over 26 IPOs. Dr. Huang spent over a decade in the automotive industry as a senior executive. In 2016, Dr. Huang founded Pasaca Capital Inc. in Pasadena, CA., and has skillfully led Pasaca from a small private equity firm to a global, evergreen fund worth billions of dollars across its many portfolio companies around the world. In 2020, Dr. Huang founded Innova Medical Group to bring rapid tests and other innovative medical products to help the world fight against the COVID-19 pandemic. Dr. Huang was recognized as Philanthropreneur of the Year by California Legislature Assembly in November 2021, and as a distinguished Asian American & Pacific Islander (AAPI) leader by the California Joint AAPI Legislative Caucus in May 2022.

Charles Huang Foundation

The Charles Huang Foundation was founded in 2020 by Dr. Huang, who was looking for meaningful ways to give back to society and help others. The vision of the Foundation is to bolster, enable, and inspire global development in education, health, and innovation. As a nonprofit public benefit corporation with a mission to accelerate and encourage education, health-related research, and entrepreneurship on a global platform, the Charles Huang Foundation works in partnership with governments, foundations, corporations, and institutions to establish educational and business opportunities that maximize the potential of aspiring scholars, researchers, and entrepreneurs. Through the Charles Huang Foundation, Dr. Huang’s personal guiding principles of humanitarianism, global visions, and strong local economies align well with value-based giving and investing to create the positive future for which we all strive.

For more information, please visit: www.charleshuangfoundation.org

Pasaca Capital Inc.

In 2016, Dr. Huang founded Pasaca Capital Inc. in Pasadena, CA and has been its chairman. Primarily focused on equity investments, Pasaca targets innovative technologies and products and help their inventors maximize their commercial values in global market through funding, strategic transformations and formulate and execute global marketing strategies. Dr. Huang has skillfully led Pasaca from a small private equity firm to a global, evergreen fund worth billions of dollars, across its various global portfolio companies in North America, Europe, Asia, and the Middle East in medical devices, pharmaceuticals, TMT, industrials & automation, and entertainment. These include Innova Medical Group, Canton Technology, ATL, Meepo Inc, Sweegen Inc., KraftPal, etc.

For more information, please visit:www.pasacacapital.com

Innova Medical Group

In 2020, Dr. Huang proposed the “mass testing and repeat testing” strategy using inexpensive, easy to use and rapid result testing products to help countries contain the spread of the SARS-COV-2 virus while safely opening economies again. To bring innovative medical products to benefit the world, Dr. Huang founded Innova Medical Group. Having delivered over 2 billion rapid tests worldwide, Innova Medical Group is a leader and the largest supplier of COVID-19 testing in the world with manufacturing facilities in USA, U.K., France, Singapore, and China. In November 2021, Innova Medical Group established a joint venture company with Sinopharm’s China National Biotech Group, to provide critical vaccines to the world population, including the highly sought-after World Health Organization (“WHO”) approved COVID-19 vaccines.

For more information, please visit:www.innovamedgroup.com